Literature DB >> 2718709

The effect of lumbar epidural analgesia on the neurobehavioural responses of newborn infants.

T Kangas-Saarela1, R Jouppila, S Alahuhta, P Jouppila, A Hollmén.   

Abstract

The effects of maternal lumbar epidural analgesia (Th10-L5) on the neonatal neurobehavioural response were studied at the ages of 3 h, 1 day, 2 days and 4-5 days. The subjects were healthy, full-term neonates, born vaginally to 15 mothers with lumbar epidural block and 19 mothers without analgesia. Those delivered with epidural analgesia scored significantly better on alertness at the age of 3 h, 2 days and 4-5 days than the control group. No other statistically significant differences were found between the groups. The formation of the two groups according to the mothers' desire for epidural analgesia may have contributed to differences in the process of labour, but with this reservation it may be suggested that lumbar epidural analgesia may enhance the infant's recovery from the stress of labour and vaginal delivery.

Entities:  

Mesh:

Year:  1989        PMID: 2718709     DOI: 10.1111/j.1399-6576.1989.tb02916.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  3 in total

Review 1.  Risk-benefit assessment of anaesthetic agents in the puerperium.

Authors:  J Kanto
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

2.  Morphological features of the neonatal brain following exposure to regional anesthesia during labor and delivery.

Authors:  Marisa N Spann; Dana Serino; Ravi Bansal; Xuejun Hao; Giancarlo Nati; Zachary Toth; Kirwan Walsh; I-Chin Chiang; Juan Sanchez-Peña; Jun Liu; Alayar Kangarlu; Feng Liu; Yunsuo Duan; Satie Shova; Jane Fried; Gregory Z Tau; Tove S Rosen; Bradley S Peterson
Journal:  Magn Reson Imaging       Date:  2014-08-30       Impact factor: 2.546

Review 3.  Effects of obstetric analgesics and anesthetics on the neonate : a review.

Authors:  Jay E Mattingly; John D'Alessio; Jaya Ramanathan
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.